The role of neoadjuvant (HER)2-targeted therapies in (HER)2-overexpressing breast cancers.
Lemieux J, Clemons M, Provencher L, Dent S, Latreille J, Mackey J, Pritchard KI, Rayson D, Verma Sh, Verma S, Wang B, Chia S.
Lemieux J, et al. Among authors: provencher l.
Curr Oncol. 2009 Sep;16(5):48-57. doi: 10.3747/co.v16i5.510.
Curr Oncol. 2009.
PMID: 19862361
Free PMC article.